Cannabis Europa: Paris 2019

February 7th and 8th Hanway Associates was proud to host Cannabis Europa in France for the first time.

Just after wrapping up the first Cannabis Europa in London last May, a surprising move towards medical cannabis reform drew our eye to France. While the whole continent is rippling with change, we learnt from our first event in London that bringing the right people together at the right time can have positive effects that long outlast a single conference’s activities. With the French National Medicines Agency (ANSM) recommending the implementation of a medical cannabis regime and the European Parliament gearing up for a vote on cannabis, this conference was perfectly timed to kickstart meaningful reform in France.

 

Over the past 12 months we've seen the rapid professionalisation of the European industry, and nowhere was this more evident than at the Maison de la Chimie on the 8th of February.

Alastair Moore, Managing Director of Cannabis Europa and COO of Hanway Associates said:

Having politicians, regulators, law firms, pharmaceutical companies and business leaders in the medical cannabis space under one roof, debating the intricate details of European cannabis policy and practice is a sight to behold.

We were delighted to have been in France, and to have provided a platform for this debate, during such a pivotal time in the country's relationship with cannabis medicines.

Welcome Reception | February 7th

On the eve of the full-day conference we kicked off Cannabis Europa with an evening of networking and introductions amongst the greenery at Paris’ beautiful Alcazar restaurant.

Full Day Conference | February 8th

AA_190208_0526.jpg
AA_190208_0549.jpg
AA_190208_1484.jpg

After fuelling up on fresh croissants from the nearest boulangerie, our team prepared to welcome our 400+ guests, speakers and partners to the Maison de la Chimie. You can read a full review of the day’s talks and see more of our highlights here.

AA_190208_0535.jpg
AA_190208_0571.jpg
AA_190208_0520.jpg

There was clear dedication and interest from the French members of parliament that spoke at the conference, and political support for medical cannabis has continued to grow, with more deputies in the Assemblée Nationale voicing their support each day.

Pierre-Yves Galléty, General Manager of Cannabis Europa and Head of External Relations at Hanway Associates said:

Thanks to the number of MPs and MEPs present, I think the conference has brought a new perspective on cannabis and how it’s perceived by national politicians in the country, that will ultimately be the driving forces of reform.

AA_190208_0517.jpg
AA_190208_0675.jpg
Hanway Associates CEO, George McBride delivering the Welcome Address to guests at Cannabis Europa Paris.

Hanway Associates CEO, George McBride delivering the Welcome Address to guests at Cannabis Europa Paris.

The thought-leading speakers that join us are crucial to what makes Cannabis Europa the foremost arena to share knowledge and shape the future of medical cannabis in Europe. In Paris we were joined by policymakers, scientists, doctors, patients, advocates, CEOs, economists, pharmacists, academics, founders and leaders from a wide variety of industries. Our guests and panels are made up of people from every corner of the globe, working together to create a sustainable, profitable industry that puts patient needs at the forefront of discussion.

AA_190208_0934.jpg
AA_190208_0898.jpg

Pierre-Yves Galléty continued:

As a Frenchman, I was delighted to bring Cannabis Europa to my country, especially since it was the first conference of its kind here. We’ve been overwhelmed by the positive feedback from all the guests: they were impressed at the level of conversation and event management we were able to bring to our first event in France.

AA_190208_1595.jpg
AA_190208_1346.jpg
AA_190208_0641.jpg

Thank you to our guests, speakers and all of the team that were a part of this day of unparalleled creativity, problem-solving, connecting and stimulating conversation.

Thank you to our partners Aurora, Bedrocan, Shimadzu, EMMAC Life Sciences, Dragonfly CBD, Canaccord Genuity, Zenabis, Phytoplant Research, BeCann, Grow Biotech, Valens and MGC Pharmaceuticals for helping make Cannabis Europa such a success.

With all eyes on Europe, our team is already preparing to bring Cannabis Europa back to London this June during European Cannabis Week. This two-day event will explore the latest developments in the UK market and the professionalisation of the industry across the European continent.

We look forward to continuing to advance this burgeoning industry with you.

AA_190208_1676.jpg
Olivia Rutter